V1	V2	V3	V4	V5	V6	V7	V8	V9	V10
admin.batchnumber	304.12.0	304.12.0	304.12.0	304.12.0	304.12.0	304.12.0	304.12.0	304.12.0	304.12.0
admin.bcr	nationwide children's hospital	nationwide children's hospital	nationwide children's hospital	nationwide children's hospital	nationwide children's hospital	nationwide children's hospital	nationwide children's hospital	nationwide children's hospital	nationwide children's hospital
admin.dayofdccupload	6	6	6	6	6	6	6	6	6
admin.diseasecode	acc	acc	acc	acc	acc	acc	acc	acc	acc
admin.monthofdccupload	2	2	2	2	2	2	2	2	2
admin.patientwithdrawal.withdrawn	false	false	false	false	false	false	false	false	false
admin.yearofdccupload	2014	2014	2014	2014	2014	2014	2014	2014	2014
patient.bcrpatientbarcode	tcga-or-a5jc	tcga-or-a5ji	tcga-or-a5jj	tcga-or-a5jm	tcga-or-a5jo	tcga-or-a5jr	tcga-or-a5k6	tcga-or-a5k9	tcga-ou-a5pi
patient.bcrpatientuuid	bdfcd747-f6a2-42e2-bc9b-483112205fa8	b7adb786-1f81-43ca-ac72-7243966cd439	9ec86c06-e7a9-4ea6-b36d-6f832909054b	fb54458d-c373-46c2-841e-82663e13efaa	4fbbbe43-3c0e-4475-bcf8-3745bd7195eb	a19104d6-b6a6-4878-af2c-783679070a05	28153e3e-8515-4852-aaa0-247f86399f27	d890cbf7-41d8-4992-99c2-24c60c77b156	a5be4e42-cb6c-4e67-8547-45dbd058bb95
patient.clinicalcqcf.anatomicneoplasmsubdivision	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.clinicalcqcf.consentordeathstatus	waiver	consented	consented	consented	consented	consented	consented	consented	consented
patient.clinicalcqcf.country	australia	australia	australia	australia	australia	united states	united states	united states	united states
patient.clinicalcqcf.daystoconsent	NA	0	1	1	0	0	755	0	-6
patient.clinicalcqcf.daystodeath	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.clinicalcqcf.diagnosissubtype	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.clinicalcqcf.histologicaltype	adrenocortical carcinoma- usual type	adrenocortical carcinoma- usual type	adrenocortical carcinoma- usual type	adrenocortical carcinoma- usual type	adrenocortical carcinoma- usual type	adrenocortical carcinoma- usual type	adrenocortical carcinoma- usual type	adrenocortical carcinoma- usual type	adrenocortical carcinoma- usual type
patient.clinicalcqcf.historyofneoadjuvanttreatment	no	no	no	yes, pharmaceutical treatment prior to resection	no	no	no	no	no
patient.clinicalcqcf.normaltissueanatomicsite	NA	NA	NA	NA	NA	NA	NA	kidney	NA
patient.clinicalcqcf.normaltissueproximity	NA	NA	NA	NA	NA	NA	NA	distal (>2cm)	NA
patient.clinicalcqcf.otheranatomicsite	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.clinicalcqcf.otherdiagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.clinicalcqcf.priordx	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.clinicalcqcf.tumorfocality	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.clinicalcqcf.tumortype	primary	primary	primary	primary	primary	primary	primary	primary	primary
patient.dayofformcompletion	17	18	3	3	18	9	8	11	16
patient.daystobirth	-13862	-8177	-24082	-9359	-9547	-16604	-20657	-22596	-19492
patient.daystodeath	1750	NA	NA	562	NA	NA	NA	344	NA
patient.daystolastfollowup	NA	1424	309	NA	889	3688	1130	NA	709
patient.drugs	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-2.bcrdrugbarcode	NA	NA	NA	tcga-or-a5jm-d49540	NA	NA	NA	NA	tcga-ou-a5pi-d45487
patient.drugs.drug-2.bcrdruguuid	NA	NA	NA	2b5dd32a-1f38-4899-a90f-77c16b1f900e	NA	NA	NA	NA	3511fdb0-aa74-42f8-a96f-22043a6186d2
patient.drugs.drug-2.clinicaltraildrugclassification	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-2.dayofformcompletion	NA	NA	NA	3	NA	NA	NA	NA	16
patient.drugs.drug-2.daystodrugtherapyend	NA	NA	NA	439	NA	NA	NA	NA	239
patient.drugs.drug-2.daystodrugtherapystart	NA	NA	NA	378	NA	NA	NA	NA	69
patient.drugs.drug-2.drugname	NA	NA	NA	ketoconazole	NA	NA	NA	NA	doxorubicin
patient.drugs.drug-2.measureofresponse	NA	NA	NA	clinical progressive disease	NA	NA	NA	NA	stable disease
patient.drugs.drug-2.monthofformcompletion	NA	NA	NA	10	NA	NA	NA	NA	7
patient.drugs.drug-2.numbercycles	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-2.prescribeddose	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-2.prescribeddoseunits	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-2.regimenindication	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-2.regimenindicationnotes	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-2.regimennumber	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-2.routeofadministrations.routeofadministration	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-2.therapyongoing	NA	NA	NA	no	NA	NA	NA	NA	no
patient.drugs.drug-2.therapytypes.therapytype	NA	NA	NA	targeted molecular therapy	NA	NA	NA	NA	chemotherapy
patient.drugs.drug-2.therapytypes.therapytypenotes	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-2.totaldose	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-2.totaldoseunits	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-2.txonclinicaltrial	NA	NA	NA	no	NA	NA	NA	NA	no
patient.drugs.drug-2.yearofformcompletion	NA	NA	NA	2013	NA	NA	NA	NA	2013
patient.drugs.drug-3.bcrdrugbarcode	NA	NA	NA	NA	NA	NA	NA	NA	tcga-ou-a5pi-d45488
patient.drugs.drug-3.bcrdruguuid	NA	NA	NA	NA	NA	NA	NA	NA	c4f9820c-381e-4ea5-86e2-c6be026baf87
patient.drugs.drug-3.clinicaltraildrugclassification	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-3.dayofformcompletion	NA	NA	NA	NA	NA	NA	NA	NA	16
patient.drugs.drug-3.daystodrugtherapyend	NA	NA	NA	NA	NA	NA	NA	NA	239
patient.drugs.drug-3.daystodrugtherapystart	NA	NA	NA	NA	NA	NA	NA	NA	55
patient.drugs.drug-3.drugname	NA	NA	NA	NA	NA	NA	NA	NA	cisplatin
patient.drugs.drug-3.measureofresponse	NA	NA	NA	NA	NA	NA	NA	NA	stable disease
patient.drugs.drug-3.monthofformcompletion	NA	NA	NA	NA	NA	NA	NA	NA	7
patient.drugs.drug-3.numbercycles	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-3.prescribeddose	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-3.prescribeddoseunits	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-3.regimenindication	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-3.regimenindicationnotes	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-3.regimennumber	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-3.routeofadministrations.routeofadministration	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-3.therapyongoing	NA	NA	NA	NA	NA	NA	NA	NA	no
patient.drugs.drug-3.therapytypes.therapytype	NA	NA	NA	NA	NA	NA	NA	NA	chemotherapy
patient.drugs.drug-3.therapytypes.therapytypenotes	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-3.totaldose	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-3.totaldoseunits	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-3.txonclinicaltrial	NA	NA	NA	NA	NA	NA	NA	NA	no
patient.drugs.drug-3.yearofformcompletion	NA	NA	NA	NA	NA	NA	NA	NA	2013
patient.drugs.drug-4.bcrdrugbarcode	NA	NA	NA	NA	NA	NA	NA	NA	tcga-ou-a5pi-d45489
patient.drugs.drug-4.bcrdruguuid	NA	NA	NA	NA	NA	NA	NA	NA	fac3df36-8c2f-4de8-aa0b-36eac3a6a9d0
patient.drugs.drug-4.clinicaltraildrugclassification	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-4.dayofformcompletion	NA	NA	NA	NA	NA	NA	NA	NA	16
patient.drugs.drug-4.daystodrugtherapyend	NA	NA	NA	NA	NA	NA	NA	NA	239
patient.drugs.drug-4.daystodrugtherapystart	NA	NA	NA	NA	NA	NA	NA	NA	69
patient.drugs.drug-4.drugname	NA	NA	NA	NA	NA	NA	NA	NA	mitotane
patient.drugs.drug-4.measureofresponse	NA	NA	NA	NA	NA	NA	NA	NA	stable disease
patient.drugs.drug-4.monthofformcompletion	NA	NA	NA	NA	NA	NA	NA	NA	7
patient.drugs.drug-4.numbercycles	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-4.prescribeddose	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-4.prescribeddoseunits	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-4.regimenindication	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-4.regimenindicationnotes	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-4.regimennumber	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-4.routeofadministrations.routeofadministration	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-4.therapyongoing	NA	NA	NA	NA	NA	NA	NA	NA	no
patient.drugs.drug-4.therapytypes.therapytype	NA	NA	NA	NA	NA	NA	NA	NA	chemotherapy
patient.drugs.drug-4.therapytypes.therapytypenotes	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-4.totaldose	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-4.totaldoseunits	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug-4.txonclinicaltrial	NA	NA	NA	NA	NA	NA	NA	NA	no
patient.drugs.drug-4.yearofformcompletion	NA	NA	NA	NA	NA	NA	NA	NA	2013
patient.drugs.drug.bcrdrugbarcode	NA	NA	NA	tcga-or-a5jm-d49539	NA	NA	NA	NA	tcga-ou-a5pi-d45486
patient.drugs.drug.bcrdruguuid	NA	NA	NA	b4f66718-b197-4efb-af9b-380b238bf6b5	NA	NA	NA	NA	dec40ba5-e688-457a-92b6-fdcc166d3321
patient.drugs.drug.clinicaltraildrugclassification	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug.dayofformcompletion	NA	NA	NA	3	NA	NA	NA	NA	16
patient.drugs.drug.daystodrugtherapyend	NA	NA	NA	439	NA	NA	NA	NA	239
patient.drugs.drug.daystodrugtherapystart	NA	NA	NA	378	NA	NA	NA	NA	69
patient.drugs.drug.drugname	NA	NA	NA	sunitinib	NA	NA	NA	NA	etoposide
patient.drugs.drug.measureofresponse	NA	NA	NA	clinical progressive disease	NA	NA	NA	NA	stable disease
patient.drugs.drug.monthofformcompletion	NA	NA	NA	10	NA	NA	NA	NA	7
patient.drugs.drug.numbercycles	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug.prescribeddose	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug.prescribeddoseunits	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug.regimenindication	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug.regimenindicationnotes	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug.regimennumber	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug.routeofadministrations.routeofadministration	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug.therapyongoing	NA	NA	NA	no	NA	NA	NA	NA	no
patient.drugs.drug.therapytypes.therapytype	NA	NA	NA	targeted molecular therapy	NA	NA	NA	NA	chemotherapy
patient.drugs.drug.therapytypes.therapytypenotes	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug.totaldose	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug.totaldoseunits	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.drugs.drug.txonclinicaltrial	NA	NA	NA	no	NA	NA	NA	NA	no
patient.drugs.drug.yearofformcompletion	NA	NA	NA	2013	NA	NA	NA	NA	2013
patient.ethnicity	NA	NA	NA	NA	NA	NA	not hispanic or latino	NA	not hispanic or latino
patient.followups	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.gender	male	male	male	female	female	male	female	female	female
patient.historyofneoadjuvanttreatment	no	no	no	yes	no	no	no	no	no
patient.icd10	c74.0	c74.0	c74.0	c74.0	c74.0	c74.0	c74.0	c74.0	c74.0
patient.icdo3histology	8370/3	8370/3	8370/3	8370/3	8370/3	8370/3	8370/3	8370/3	8370/3
patient.icdo3site	c74.0	c74.0	c74.0	c74.0	c74.0	c74.0	c74.0	c74.0	c74.0
patient.informedconsentverified	yes	yes	yes	yes	yes	yes	yes	yes	yes
patient.mitotanetherapy	NA	no	yes	yes	no	no	yes	yes	yes
patient.mitotanetherapyadjuvantsetting	NA	NA	NA	yes	NA	NA	no	yes	yes
patient.mitotanetherapyformacroscopicresidualdisease	NA	NA	NA	NA	NA	NA	yes	NA	no
patient.monthofformcompletion	9	9	10	10	9	9	10	9	7
patient.newtumorevents.newtumorevent-2.additionalpharmaceuticaltherapy	NA	NA	NA	NA	NA	NA	no	NA	NA
patient.newtumorevents.newtumorevent-2.additionalradiationtherapy	NA	NA	NA	NA	NA	NA	no	NA	NA
patient.newtumorevents.newtumorevent-2.daystonewtumoreventadditionalsurgeryprocedure	NA	NA	NA	NA	NA	NA	972	NA	NA
patient.newtumorevents.newtumorevent-2.daystonewtumoreventafterinitialtreatment	NA	NA	NA	NA	NA	NA	391	236	NA
patient.newtumorevents.newtumorevent-2.histologicdiseaseprogressionpresentindicator	NA	NA	NA	NA	NA	NA	yes	NA	NA
patient.newtumorevents.newtumorevent-2.newneoplasmconfirmeddiagnosismethodname	NA	NA	NA	NA	NA	NA	imaging	imaging	NA
patient.newtumorevents.newtumorevent-2.newneoplasmeventoccurrenceanatomicsite	NA	NA	NA	NA	NA	NA	liver	lymph node(s)	NA
patient.newtumorevents.newtumorevent-2.newneoplasmeventtype	NA	NA	NA	NA	NA	NA	distant metastasis	locoregional recurrence	NA
patient.newtumorevents.newtumorevent-2.newneoplasmoccurrenceanatomicsitetext	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.newtumorevents.newtumorevent-2.newtumoreventadditionalsurgeryprocedure	NA	NA	NA	NA	NA	NA	yes	NA	NA
patient.newtumorevents.newtumorevent-3.additionalpharmaceuticaltherapy	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.newtumorevents.newtumorevent-3.additionalradiationtherapy	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.newtumorevents.newtumorevent-3.daystonewtumoreventadditionalsurgeryprocedure	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.newtumorevents.newtumorevent-3.daystonewtumoreventafterinitialtreatment	NA	NA	NA	NA	NA	NA	NA	236	NA
patient.newtumorevents.newtumorevent-3.histologicdiseaseprogressionpresentindicator	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.newtumorevents.newtumorevent-3.newneoplasmconfirmeddiagnosismethodname	NA	NA	NA	NA	NA	NA	NA	imaging	NA
patient.newtumorevents.newtumorevent-3.newneoplasmeventoccurrenceanatomicsite	NA	NA	NA	NA	NA	NA	NA	lung	NA
patient.newtumorevents.newtumorevent-3.newneoplasmeventtype	NA	NA	NA	NA	NA	NA	NA	distant metastasis	NA
patient.newtumorevents.newtumorevent-3.newneoplasmoccurrenceanatomicsitetext	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.newtumorevents.newtumorevent-3.newtumoreventadditionalsurgeryprocedure	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.newtumorevents.newtumorevent-4.additionalpharmaceuticaltherapy	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.newtumorevents.newtumorevent-4.additionalradiationtherapy	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.newtumorevents.newtumorevent-4.daystonewtumoreventadditionalsurgeryprocedure	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.newtumorevents.newtumorevent-4.daystonewtumoreventafterinitialtreatment	NA	NA	NA	NA	NA	NA	NA	236	NA
patient.newtumorevents.newtumorevent-4.histologicdiseaseprogressionpresentindicator	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.newtumorevents.newtumorevent-4.newneoplasmconfirmeddiagnosismethodname	NA	NA	NA	NA	NA	NA	NA	imaging	NA
patient.newtumorevents.newtumorevent-4.newneoplasmeventoccurrenceanatomicsite	NA	NA	NA	NA	NA	NA	NA	liver	NA
patient.newtumorevents.newtumorevent-4.newneoplasmeventtype	NA	NA	NA	NA	NA	NA	NA	distant metastasis	NA
patient.newtumorevents.newtumorevent-4.newneoplasmoccurrenceanatomicsitetext	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.newtumorevents.newtumorevent-4.newtumoreventadditionalsurgeryprocedure	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.newtumorevents.newtumorevent.additionalpharmaceuticaltherapy	NA	NA	NA	yes	NA	NA	no	NA	yes
patient.newtumorevents.newtumorevent.additionalradiationtherapy	NA	NA	NA	NA	NA	NA	no	NA	yes
patient.newtumorevents.newtumorevent.daystonewtumoreventadditionalsurgeryprocedure	NA	NA	NA	NA	NA	NA	972	NA	384
patient.newtumorevents.newtumorevent.daystonewtumoreventafterinitialtreatment	NA	NA	NA	72	NA	NA	391	236	351
patient.newtumorevents.newtumorevent.histologicdiseaseprogressionpresentindicator	NA	NA	NA	NA	NA	NA	yes	NA	no
patient.newtumorevents.newtumorevent.newneoplasmconfirmeddiagnosismethodname	NA	NA	NA	imaging	NA	NA	imaging	imaging	imaging
patient.newtumorevents.newtumorevent.newneoplasmeventoccurrenceanatomicsite	NA	NA	NA	liver	NA	NA	peritoneal surfaces	peritoneal surfaces	lung
patient.newtumorevents.newtumorevent.newneoplasmeventtype	NA	NA	NA	distant metastasis	NA	NA	locoregional recurrence	locoregional recurrence	distant metastasis
patient.newtumorevents.newtumorevent.newneoplasmoccurrenceanatomicsitetext	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.newtumorevents.newtumorevent.newtumoreventadditionalsurgeryprocedure	NA	NA	NA	no	NA	NA	yes	NA	yes
patient.newtumorevents.newtumoreventafterinitialtreatment	NA	no	NA	yes	no	no	yes	yes	yes
patient.patientid	a5jc	a5ji	a5jj	a5jm	a5jo	a5jr	a5k6	a5k9	a5pi
patient.personneoplasmcancerstatus	NA	tumor free	with tumor	with tumor	tumor free	tumor free	with tumor	with tumor	with tumor
patient.postoperativerxtx	NA	no	no	yes	no	no	no	no	yes
patient.postsurgicalprocedureassessmentthyroidglandcarcinomastatus	NA	no imaging evidence of disease	persistent distant metastases	biochemical evidence of disease	no imaging evidence of disease	no imaging evidence of disease	no imaging evidence of disease	no imaging evidence of disease	persistent distant metastases
patient.primarypathology.ageatinitialpathologicdiagnosis	37	22	65	25	26	45	56	61	53
patient.primarypathology.ctscan	NA	yes	yes	yes	yes	yes	yes	yes	yes
patient.primarypathology.ctscanfindings	NA	normal	lung involvement	liver involvement	normal	NA	normal	NA	lung involvement
patient.primarypathology.daystoinitialpathologicdiagnosis	0	0	0	0	0	0	0	0	0
patient.primarypathology.excessadrenalhormonehistorytypes.excessadrenalhormonediagnosismethodtype	biochemical assessment	NA	NA	both clinical and biochemical assessments	NA	NA	both clinical and biochemical assessments	both clinical and biochemical assessments	NA
patient.primarypathology.excessadrenalhormonehistorytypes.excessadrenalhormonehistorytype	estrogen	none	none	cortisol	none	none	cortisol	androgen	none
patient.primarypathology.excessadrenalhormonehistorytypes.excessadrenalhormonehistorytype-2	NA	NA	NA	NA	NA	NA	NA	cortisol	NA
patient.primarypathology.germlinegenotypetestingreport.germlinegenotypetestcategories.max	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.primarypathology.germlinegenotypetestingreport.germlinegenotypetestcategories.nf1	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.primarypathology.germlinegenotypetestingreport.germlinegenotypetestcategories.nf1clinicaldiagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.primarypathology.germlinegenotypetestingreport.germlinegenotypetestcategories.ret	NA	NA	NA	NA	NA	NA	NA	NA	ret negative
patient.primarypathology.germlinegenotypetestingreport.germlinegenotypetestcategories.sdha	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.primarypathology.germlinegenotypetestingreport.germlinegenotypetestcategories.sdhaf2sdh5	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.primarypathology.germlinegenotypetestingreport.germlinegenotypetestcategories.sdhb	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.primarypathology.germlinegenotypetestingreport.germlinegenotypetestcategories.sdhc	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.primarypathology.germlinegenotypetestingreport.germlinegenotypetestcategories.sdhd	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.primarypathology.germlinegenotypetestingreport.germlinegenotypetestcategories.tmem127	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.primarypathology.germlinegenotypetestingreport.germlinegenotypetestcategories.vhl	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.primarypathology.germlinegenotypetestingreport.molecularanalysisperformedindicator	no	no	yes	no	no	yes	NA	NA	yes
patient.primarypathology.histologicaltype	adrenocortical carcinoma- usual type	adrenocortical carcinoma- usual type	adrenocortical carcinoma- usual type	adrenocortical carcinoma- usual type	adrenocortical carcinoma- usual type	adrenocortical carcinoma- usual type	adrenocortical carcinoma- usual type	adrenocortical carcinoma- usual type	adrenocortical carcinoma- usual type
patient.primarypathology.laterality	left	right	left	left	right	left	left	right	left
patient.primarypathology.lymphnodeexaminedcount	NA	NA	6	NA	NA	NA	NA	NA	3
patient.primarypathology.metastaticneoplasmconfirmeddiagnosismethodnames.metastaticneoplasmconfirmeddiagnosismethodname	NA	NA	NA	other, specify	NA	NA	NA	NA	other, specify
patient.primarypathology.metastaticneoplasmconfirmeddiagnosismethodnames.metastaticneoplasmconfirmeddiagnosismethodtext	NA	NA	NA	NA	NA	NA	NA	NA	resection
patient.primarypathology.metastaticneoplasminitialdiagnosisanatomicsites.distantmetastasisanatomicsite	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.primarypathology.metastaticneoplasminitialdiagnosisanatomicsites.metastaticneoplasminitialdiagnosisanatomicsite	NA	NA	lung	liver	NA	NA	NA	NA	lung
patient.primarypathology.mitosescount	24	1	50	90	2	NA	7	NA	NA
patient.primarypathology.numberoflymphnodespositivebyhe	NA	NA	6	NA	NA	NA	NA	NA	3
patient.primarypathology.primarylymphnodepresentationassessment	no	no	yes	NA	no	no	no	no	yes
patient.primarypathology.residualtumor	NA	r0	r2	r1	r0	r0	r0	r0	NA
patient.primarypathology.tumortissuesite	adrenal	adrenal	adrenal	adrenal	adrenal	adrenal	adrenal	adrenal	adrenal
patient.primarypathology.weissassessmentreport.weissassessmentcategories.atypicalmitoticfigures	atypical mitotic figures present	atypical mitotic figures absent	atypical mitotic figures present	atypical mitotic figures present	atypical mitotic figures absent	NA	atypical mitotic figures present	NA	atypical mitotic figures absent
patient.primarypathology.weissassessmentreport.weissassessmentcategories.cytoplasmpresencelessthanequal25percent	cytoplasm presence <= 25% present	cytoplasm presence <= 25% present	cytoplasm presence <= 25% present	cytoplasm presence <= 25% present	cytoplasm presence <= 25% absent	NA	cytoplasm presence <= 25% present	NA	cytoplasm presence <= 25% absent
patient.primarypathology.weissassessmentreport.weissassessmentcategories.diffusearchitecture	diffuse architecture present	diffuse architecture present	diffuse architecture present	diffuse architecture present	diffuse architecture present	diffuse architecture absent	diffuse architecture absent	NA	diffuse architecture absent
patient.primarypathology.weissassessmentreport.weissassessmentcategories.invasionoftumorcapsule	invasion of tumor capsule absent	invasion of tumor capsule absent	invasion of tumor capsule present	invasion of tumor capsule present	invasion of tumor capsule absent	invasion of tumor capsule present	invasion of tumor capsule absent	NA	invasion of tumor capsule present
patient.primarypathology.weissassessmentreport.weissassessmentcategories.mitoticrate	mitotic rate > 5/50 hpf present	mitotic rate > 5/50 hpf absent	mitotic rate > 5/50 hpf present	mitotic rate > 5/50 hpf present	mitotic rate > 5/50 hpf absent	NA	mitotic rate > 5/50 hpf present	NA	mitotic rate > 5/50 hpf absent
patient.primarypathology.weissassessmentreport.weissassessmentcategories.necrosis	necrosis present	necrosis absent	necrosis present	necrosis present	necrosis absent	necrosis absent	necrosis present	NA	necrosis present
patient.primarypathology.weissassessmentreport.weissassessmentcategories.nucleargradeiiiiv	nuclear grade iii or iv present	nuclear grade iii or iv present	nuclear grade iii or iv present	nuclear grade iii or iv present	nuclear grade iii or iv present	nuclear grade iii or iv absent	nuclear grade iii or iv present	NA	nuclear grade iii or iv absent
patient.primarypathology.weissassessmentreport.weissassessmentcategories.sinusoidinvasion	sinusoid invasion present	sinusoid invasion absent	sinusoid invasion present	sinusoid invasion present	sinusoid invasion absent	sinusoid invasion absent	sinusoid invasion absent	NA	sinusoid invasion absent
patient.primarypathology.weissassessmentreport.weissassessmentcategories.weissvenousinvasion	venous invasion present	venous invasion absent	venous invasion present	venous invasion present	venous invasion present	venous invasion absent	venous invasion absent	NA	venous invasion absent
patient.primarypathology.weissassessmentreport.weissscore	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.primarypathology.yearofinitialpathologicdiagnosis	2001	2008	2009	2011	2005	2002	2010	2002	2011
patient.primarytherapyoutcomesuccess	NA	NA	NA	progressive disease	NA	complete remission/response	complete remission/response	NA	stable disease
patient.priordx	no	no	no	no	no	no	no	no	no
patient.race	white	white	white	white	white	white	white	white	white
patient.radiations	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.radiations.radiation.anatomictreatmentsite	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.radiations.radiation.bcrradiationbarcode	NA	NA	NA	tcga-or-a5jm-r49541	NA	NA	NA	NA	NA
patient.radiations.radiation.bcrradiationuuid	NA	NA	NA	e1eca707-21ff-43dd-8591-ebcbe2e5e1a7	NA	NA	NA	NA	NA
patient.radiations.radiation.coursenumber	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.radiations.radiation.dayofformcompletion	NA	NA	NA	3	NA	NA	NA	NA	NA
patient.radiations.radiation.daystoradiationtherapyend	NA	NA	NA	196	NA	NA	NA	NA	NA
patient.radiations.radiation.daystoradiationtherapystart	NA	NA	NA	134	NA	NA	NA	NA	NA
patient.radiations.radiation.measureofresponse	NA	NA	NA	radiographic progressive disease	NA	NA	NA	NA	NA
patient.radiations.radiation.monthofformcompletion	NA	NA	NA	10	NA	NA	NA	NA	NA
patient.radiations.radiation.numfractions	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.radiations.radiation.radiationdosage	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.radiations.radiation.radiationtreatmentongoing	NA	NA	NA	no	NA	NA	NA	NA	NA
patient.radiations.radiation.radiationtype	NA	NA	NA	internal	NA	NA	NA	NA	NA
patient.radiations.radiation.radiationtypenotes	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.radiations.radiation.regimenindication	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.radiations.radiation.regimenindicationnotes	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.radiations.radiation.units	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.radiations.radiation.yearofformcompletion	NA	NA	NA	2013	NA	NA	NA	NA	NA
patient.radiationtherapy	NA	no	no	yes	no	no	no	no	no
patient.stageevent.annarbor.bsymptoms	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.annarbor.extranodalinvolvement	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.clinicalstage	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.gleasongrading.gleasonscore	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.gleasongrading.primarypattern	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.gleasongrading.secondarypattern	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.gleasongrading.tertiarypattern	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.pathologicstage	NA	stage i	stage iv	stage iv	stage i	stage i	stage ii	stage ii	stage iv
patient.stageevent.psa.daystopsa	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.psa.psavalue	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.systemversion	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.tnmcategories.clinicalcategories.clinicalm	NA	m0	m1	m1	m0	m0	m0	m0	m1
patient.stageevent.tnmcategories.clinicalcategories.clinicaln	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.tnmcategories.clinicalcategories.clinicalt	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.tnmcategories.pathologiccategories.pathologicm	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.tnmcategories.pathologiccategories.pathologicn	NA	n0	n1	n0	n0	n0	n0	n0	n1
patient.stageevent.tnmcategories.pathologiccategories.pathologict	NA	t1	t4	t4	t1	t1	t2	t2	t2
patient.therapeuticmitotanelevelsachieved	NA	NA	NA	NA	NA	NA	no	NA	NA
patient.therapeuticmitotanelvlmacroscopicresidual	NA	NA	NA	NA	NA	NA	yes	NA	NA
patient.therapeuticmitotanelvlprogression	NA	NA	NA	NA	NA	NA	yes	NA	NA
patient.therapeuticmitotanelvlrecurrence	NA	NA	NA	NA	NA	NA	no	NA	NA
patient.tissueprospectivecollectionindicator	no	no	no	no	no	no	yes	no	no
patient.tissueretrospectivecollectionindicator	yes	yes	yes	yes	yes	yes	no	yes	yes
patient.tissuesourcesite	or	or	or	or	or	or	or	or	ou
patient.vitalstatus	dead	alive	alive	dead	alive	alive	alive	dead	alive
patient.yearofformcompletion	2013	2013	2013	2013	2013	2013	2013	2013	2013
